Two approaches were chosen to assess the controversially debated influ
ence of acetate on the heart in dialysis patients: (1) To separate ace
tate effects from influences of dialysis, acetate was infused in 12 ch
ronic dialysis patients with normal systolic function on a dialysis-fr
ee day, and left ventricular (LV) function was assessed by LV pressure
/volume loops. Hyperacetatemia (3-5 mmol/l) resulted in a decrease in
LV preload (LV end-diastolic pressure decreased from 16 +/- 3 to 10 +/
- 4 mm Hg, p < 0.01) but had no influence on LV contractility. (2) In
8 dialysis patients without cardiac disease, isovolemic acetate or bic
arbonate dialysis was performed. During both procedures, there were co
mparable changes in serum electrolytes as well as in echocardiographic
parameters. LV contractility measured by velocity of circumferential
fiber shortening increased during acetate and bicarbonate dialysis (1.
47 +/- 0.22 to 1.77 +/- 0.29, p < 0.01; 1.47 +/- 0.21 to 1.70 +/- 0.22
circ/s, p < 0.01. It is concluded that mild hyperacetatemia does not
influence LV contractility and that dialysis-induced changes in serum
electrolytes are responsible for the increase in LV contractility duri
ng dialysis. However, the pronounced acetate effect on LV preload impl
ies considerable therapeutic implications.